Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway

Luojie Liu; Lihua Zhu; Zhengwu Cheng; Yibin Sun; Yuqing Zhou; Jiwei Cao

doi:doi:10.18632/aging.205041

← Back

Research Paper Volume 15, Issue 18 pp 9661—9675

Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway

Figure 2. The overall survival analysis of AKR1B1^pos vs. AKR1B1^neg GC patients in subgroups has been demarcated based on individual clinicopathological indicators.